EU Commission to end AstraZeneca and J&J vaccine contracts at expiry

The European Commission has decided not to renew Covid-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson. File picture

The European Commission has decided not to renew Covid-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday, citing a source from the Italian health ministry.

“The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry,” the newspaper reported.